For the year ending 2025-12-31, STRA had $2,855K increase in cash & cash equivalents over the period. $153,946K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income | 126,614 |
| Gain on sale of property and equipment | 0 |
| Gain on early termination of operating leases | 2,196 |
| Amortization of deferred financing costs | 425 |
| Amortization of investment discount/premium | 432 |
| Depreciation and amortization | 48,410 |
| Deferred income taxes | 7,733 |
| Stock-based compensation | 22,954 |
| Impairment of right-of-use lease assets | 4,685 |
| Tuition receivable, net | 1,086 |
| Other assets | 7,593 |
| Accounts payable and accrued expenses | 4,222 |
| Income taxes payable and income taxes receivable | -5,563 |
| Contract liabilities | 6,062 |
| Other liabilities | -6,037 |
| Net cash provided by operating activities | 198,198 |
| Purchases of property and equipment | 44,252 |
| Purchases of marketable securities | 28,094 |
| Proceeds from marketable securities | 79,078 |
| Proceeds from sale of property and equipment | 2,200 |
| Proceeds from other investments | 0 |
| Other investments | 390 |
| Cash paid for acquisition, net of cash acquired | 36 |
| Net cash provided by (used in) investing activities | 8,506 |
| Common dividends paid | 57,543 |
| Payments on long-term debt | 0 |
| Net payments for stock awards | 9,720 |
| Payments of deferred financing costs | 0 |
| Repurchase of common stock | 138,892 |
| Net cash used in financing activities | -206,155 |
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | 2,306 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 2,855 |
| Cash, cash equivalents, and restricted cash beginning of period | 146,656 |
| Cash, cash equivalents, and restricted cash end of period | 149,511 |